MAD2L2 Dimerization Is Not Essential for Mitotic Regulation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111485 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nomi Barda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology Department, Ariel University, Ariel 40700, Israel. Hauptthemen laut MEDLINE: Mitosis, Mad2 Proteins, Protein Multimerization. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ariel University, the Israel Cancer Association, Israel Innovation Authority KAMIN program.
Abstract (Originalsprache)
MAD2L2 is a small HORMA domain protein that plays a crucial role in DNA repair and mitosis. In both TLS and shieldin, the dimerization of MAD2L2 via its HORMA domain is critical for the stability and function of these complexes. However, in mitosis, the dimerization state of MAD2L2 remains unknown. To assess the importance of MAD2L2’s dimerization during mitosis, we utilized CRISPR/Cas9 to generate MAD2L2 knockout cells, which were subsequently complemented with MAD2L2 species carrying different dimer-disrupting point mutations. We assessed the ability of these MAD2L2 dimer-disrupting mutants to regulate mitosis by evaluating early mitotic events and mitotic fidelity. Our findings indicate that MAD2L2 can function in its monomeric form during mitosis, suggesting that MAD2L2 homodimerization is dispensable for early mitotic regulation. Furthermore, our results suggest that the binding of CDH1 to MAD2L2 is a key regulating factor in mitosis that may actively prevent the formation of MAD2L2 dimers, thereby shifting the cellular balance toward MAD2L2-CDH1 interaction. Thus, the equilibrium between the monomeric and dimeric forms of MAD2L2 is an important cellular factor regulating the MAD2L2-containing complexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biology Department, Ariel University, Ariel 40700, Israel.
- Adelson School of Medicine, Ariel University, Ariel 40700, Israel.
ORCID-Profile: Philippa Jennifer Ayiku, Tamar Listovsky
Förderung
- Ariel University
- the Israel Cancer Association
- Israel Innovation Authority KAMIN program
- Israel Cancer Association
Zitieren
APA
Barda, N., Ayiku, P. J., Bar-On, A., Movshovitz, S., & Listovsky, T. (2024). MAD2L2 Dimerization Is Not Essential for Mitotic Regulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111485
Vancouver
Barda N, Ayiku PJ, Bar-On A, Movshovitz S, Listovsky T. MAD2L2 Dimerization Is Not Essential for Mitotic Regulation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111485
BibTeX
@article{Barda2024,
author = {Barda, Nomi and Ayiku, Philippa Jennifer and Bar-On, Amit and Movshovitz, Sahar and Listovsky, Tamar},
title = {MAD2L2 Dimerization Is Not Essential for Mitotic Regulation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111485}
}
EUVIMED